Swiss All Share Index
17.806,90
PKT
-162,22
PKT
-0,90
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.06.12 | Novartis hold | Vontobel Research | |
| 08.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 08.06.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 08.06.12 | UBS buy | WestLB AG | |
| 08.06.12 | Logitech neutral | Sarasin Research | |
| 08.06.12 | Logitech hold | Vontobel Research | |
| 08.06.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 07.06.12 | Avolta (ex Dufry) neutral | Sarasin Research | |
| 07.06.12 | Avolta (ex Dufry) hold | Vontobel Research | |
| 06.06.12 | Holcim neutral | Goldman Sachs Group Inc. | |
| 06.06.12 | Holcim sell | Goldman Sachs Group Inc. | |
| 06.06.12 | Geberit hold | Vontobel Research | |
| 06.06.12 | ARYZTA buy | Vontobel Research | |
| 05.06.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 05.06.12 | ARYZTA neutral | Sarasin Research | |
| 05.06.12 | ARYZTA buy | Vontobel Research | |
| 05.06.12 | Novartis hold | Vontobel Research | |
| 04.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 04.06.12 | Swiss Re neutral | Exane-BNP Paribas SA | |
| 04.06.12 | Novartis neutral | Citigroup Corp. | |
| 04.06.12 | Avolta (ex Dufry) neutral | Sarasin Research | |
| 04.06.12 | Straumann hold | Vontobel Research | |
| 04.06.12 | Novartis hold | Vontobel Research | |
| 04.06.12 | Zurich Insurance buy | Vontobel Research | |
| 01.06.12 | Swiss Re buy | UBS AG | |
| 01.06.12 | Swiss Re hold | Société Générale Group S.A. (SG) | |
| 01.06.12 | Kühne + Nagel International underperform | Cheuvreux SA | |
| 01.06.12 | Lonza hold | Vontobel Research | |
| 31.05.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 31.05.12 | ABB (Asea Brown Boveri) neutral | Exane-BNP Paribas SA | |
| 31.05.12 | Swiss Re buy | Sarasin Research | |
| 31.05.12 | Swiss Re add | Commerzbank Corp. & Markets | |
| 31.05.12 | Avolta (ex Dufry) buy | ING | |
| 31.05.12 | Holcim overweight | Morgan Stanley | |
| 31.05.12 | Holcim equal-weight | Morgan Stanley | |
| 31.05.12 | Swiss Life hold | Société Générale Group S.A. (SG) | |
| 31.05.12 | Swiss Re buy | Vontobel Research | |
| 31.05.12 | SHL Telemedicine hold | Vontobel Research | |
| 31.05.12 | Novartis buy | Deutsche Bank AG | |
| 30.05.12 | Novartis outperform | Credit Suisse Group |